Global Pneumococcal Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
Feb, 2020
|
Report ID: 117017
|
101
|
Pharmaceuticals and Healthcare
Summary
Market Overview
The global Pneumococcal Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.1% in the forecast period of 2020 to 2025 and will expected to reach USD 7551.8 million by 2025, from USD 7242 million in 2019.
The Pneumococcal Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Pneumococcal Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Pneumococcal Vaccine
market has been segmented into PPSV 23, PCV 7/13, PCV 10, etc.
By Application, Pneumococcal Vaccine has been segmented into Child, Adult, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pneumococcal Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Pneumococcal Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pneumococcal Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Pneumococcal Vaccine market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Pneumococcal Vaccine markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Pneumococcal Vaccine Market Share Analysis
Pneumococcal Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pneumococcal Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pneumococcal Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Pneumococcal Vaccine are: Pfizer, Sanofipasteur, GSK, MSD, CDIBP, etc. Among other players domestic and global, Pneumococcal Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pneumococcal Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pneumococcal Vaccine, with price, sales, revenue and global market share of Pneumococcal Vaccine in 2018 and 2019.
Chapter 3, the Pneumococcal Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pneumococcal Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Pneumococcal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Pneumococcal Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Market Overview
The global Pneumococcal Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.1% in the forecast period of 2020 to 2025 and will expected to reach USD 7551.8 million by 2025, from USD 7242 million in 2019.
The Pneumococcal Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Pneumococcal Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Pneumococcal Vaccine
market has been segmented into PPSV 23, PCV 7/13, PCV 10, etc.
By Application, Pneumococcal Vaccine has been segmented into Child, Adult, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pneumococcal Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Pneumococcal Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pneumococcal Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Pneumococcal Vaccine market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Pneumococcal Vaccine markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Pneumococcal Vaccine Market Share Analysis
Pneumococcal Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pneumococcal Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pneumococcal Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Pneumococcal Vaccine are: Pfizer, Sanofipasteur, GSK, MSD, CDIBP, etc. Among other players domestic and global, Pneumococcal Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pneumococcal Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pneumococcal Vaccine, with price, sales, revenue and global market share of Pneumococcal Vaccine in 2018 and 2019.
Chapter 3, the Pneumococcal Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pneumococcal Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Pneumococcal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Pneumococcal Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Pneumococcal Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pneumococcal Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 PPSV 23
1.2.3 PCV 7/13
1.2.4 PCV 10
1.3 Market Analysis by Application
1.3.1 Overview: Global Pneumococcal Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Child
1.3.3 Adult
1.4 Overview of Global Pneumococcal Vaccine Market
1.4.1 Global Pneumococcal Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofipasteur
2.2.1 Sanofipasteur Details
2.2.2 Sanofipasteur Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofipasteur SWOT Analysis
2.2.4 Sanofipasteur Product and Services
2.2.5 Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GSK SWOT Analysis
2.3.4 GSK Product and Services
2.3.5 GSK Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 MSD
2.4.1 MSD Details
2.4.2 MSD Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 MSD SWOT Analysis
2.4.4 MSD Product and Services
2.4.5 MSD Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 CDIBP
2.5.1 CDIBP Details
2.5.2 CDIBP Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 CDIBP SWOT Analysis
2.5.4 CDIBP Product and Services
2.5.5 CDIBP Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Pneumococcal Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Pneumococcal Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Pneumococcal Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Pneumococcal Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Pneumococcal Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Pneumococcal Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Pneumococcal Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Pneumococcal Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Pneumococcal Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Pneumococcal Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Pneumococcal Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Pneumococcal Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Pneumococcal Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
6.4 France Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Pneumococcal Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Pneumococcal Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Pneumococcal Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7.5 India Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Pneumococcal Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Pneumococcal Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Pneumococcal Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Pneumococcal Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Pneumococcal Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Pneumococcal Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Pneumococcal Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Pneumococcal Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Pneumococcal Vaccine Price by Type (2015-2020)
11 Global Pneumococcal Vaccine Market Segment by Application
11.1 Global Pneumococcal Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Pneumococcal Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Pneumococcal Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Pneumococcal Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Pneumococcal Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Pneumococcal Vaccine Market Forecast (2021-2025)
12.2.2 Europe Pneumococcal Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Pneumococcal Vaccine Market Forecast (2021-2025)
12.2.4 South America Pneumococcal Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Pneumococcal Vaccine Market Forecast (2021-2025)
12.3 Pneumococcal Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Pneumococcal Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Pneumococcal Vaccine Market Share Forecast by Type (2021-2025)
12.4 Pneumococcal Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Pneumococcal Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Pneumococcal Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
1 Market Overview
1.1 Pneumococcal Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pneumococcal Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 PPSV 23
1.2.3 PCV 7/13
1.2.4 PCV 10
1.3 Market Analysis by Application
1.3.1 Overview: Global Pneumococcal Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Child
1.3.3 Adult
1.4 Overview of Global Pneumococcal Vaccine Market
1.4.1 Global Pneumococcal Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofipasteur
2.2.1 Sanofipasteur Details
2.2.2 Sanofipasteur Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofipasteur SWOT Analysis
2.2.4 Sanofipasteur Product and Services
2.2.5 Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GSK SWOT Analysis
2.3.4 GSK Product and Services
2.3.5 GSK Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 MSD
2.4.1 MSD Details
2.4.2 MSD Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 MSD SWOT Analysis
2.4.4 MSD Product and Services
2.4.5 MSD Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 CDIBP
2.5.1 CDIBP Details
2.5.2 CDIBP Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 CDIBP SWOT Analysis
2.5.4 CDIBP Product and Services
2.5.5 CDIBP Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Pneumococcal Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Pneumococcal Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Pneumococcal Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Pneumococcal Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Pneumococcal Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Pneumococcal Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Pneumococcal Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Pneumococcal Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Pneumococcal Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Pneumococcal Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Pneumococcal Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Pneumococcal Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Pneumococcal Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
6.4 France Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Pneumococcal Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Pneumococcal Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Pneumococcal Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7.5 India Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Pneumococcal Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Pneumococcal Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Pneumococcal Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Pneumococcal Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Pneumococcal Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Pneumococcal Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Pneumococcal Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Pneumococcal Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Pneumococcal Vaccine Price by Type (2015-2020)
11 Global Pneumococcal Vaccine Market Segment by Application
11.1 Global Pneumococcal Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Pneumococcal Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Pneumococcal Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Pneumococcal Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Pneumococcal Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Pneumococcal Vaccine Market Forecast (2021-2025)
12.2.2 Europe Pneumococcal Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Pneumococcal Vaccine Market Forecast (2021-2025)
12.2.4 South America Pneumococcal Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Pneumococcal Vaccine Market Forecast (2021-2025)
12.3 Pneumococcal Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Pneumococcal Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Pneumococcal Vaccine Market Share Forecast by Type (2021-2025)
12.4 Pneumococcal Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Pneumococcal Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Pneumococcal Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
List of Tables
Table 1. Global Pneumococcal Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pneumococcal Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pneumococcal Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Pneumococcal Vaccine Major Business
Table 9. Pfizer Pneumococcal Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. Pfizer SWOT Analysis
Table 11. Pfizer Pneumococcal Vaccine Product and Services
Table 12. Pfizer Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Sanofipasteur Basic Information, Manufacturing Base and Competitors
Table 14. Sanofipasteur Pneumococcal Vaccine Major Business
Table 15. Sanofipasteur Pneumococcal Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. Sanofipasteur SWOT Analysis
Table 17. Sanofipasteur Pneumococcal Vaccine Product and Services
Table 18. Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. GSK Basic Information, Manufacturing Base and Competitors
Table 20. GSK Pneumococcal Vaccine Major Business
Table 21. GSK Pneumococcal Vaccine Total Revenue (USD Million) (2017-2018)
Table 22. GSK SWOT Analysis
Table 23. GSK Pneumococcal Vaccine Product and Services
Table 24. GSK Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. MSD Basic Information, Manufacturing Base and Competitors
Table 26. MSD Pneumococcal Vaccine Major Business
Table 27. MSD Pneumococcal Vaccine Total Revenue (USD Million) (2017-2018)
Table 28. MSD SWOT Analysis
Table 29. MSD Pneumococcal Vaccine Product and Services
Table 30. MSD Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. CDIBP Basic Information, Manufacturing Base and Competitors
Table 32. CDIBP Pneumococcal Vaccine Major Business
Table 33. CDIBP Pneumococcal Vaccine Total Revenue (USD Million) (2017-2018)
Table 34. CDIBP SWOT Analysis
Table 35. CDIBP Pneumococcal Vaccine Product and Services
Table 36. CDIBP Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Pneumococcal Vaccine Sales by Manufacturer (2018-2019) (K Doses)
Table 38. Global Pneumococcal Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Pneumococcal Vaccine Sales by Regions (2015-2020) (K Doses)
Table 40. Global Pneumococcal Vaccine Sales Market Share by Regions (2015-2020)
Table 41. Global Pneumococcal Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Pneumococcal Vaccine Sales by Countries (2015-2020) (K Doses)
Table 43. North America Pneumococcal Vaccine Sales Market Share by Countries (2015-2020)
Table 44. North America Pneumococcal Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Pneumococcal Vaccine Revenue Market Share by Countries (2015-2020)
Table 46. Europe Pneumococcal Vaccine Sales by Countries (2015-2020) (K Doses)
Table 47. Europe Pneumococcal Vaccine Sales Market Share by Countries (2015-2020)
Table 48. Europe Pneumococcal Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Pneumococcal Vaccine Sales by Regions (2015-2020) (K Doses)
Table 50. Asia-Pacific Pneumococcal Vaccine Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Pneumococcal Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Pneumococcal Vaccine Sales by Countries (2015-2020) (K Doses)
Table 53. South America Pneumococcal Vaccine Sales Market Share by Countries (2015-2020)
Table 54. South America Pneumococcal Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Pneumococcal Vaccine Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Pneumococcal Vaccine Sales by Countries (2015-2020) (K Doses)
Table 57. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Pneumococcal Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Pneumococcal Vaccine Revenue Market Share by Countries (2015-2020)
Table 60. Global Pneumococcal Vaccine Sales by Type (2015-2020) (K Doses)
Table 61. Global Pneumococcal Vaccine Sales Share by Type (2015-2020)
Table 62. Global Pneumococcal Vaccine Revenue by Type (2015-2020) (USD Million)
Table 63. Global Pneumococcal Vaccine Revenue Share by Type (2015-2020)
Table 64. Global Pneumococcal Vaccine Sales by Application (2015-2020) (K Doses)
Table 65. Global Pneumococcal Vaccine Sales Share by Application (2015-2020)
Table 66. Global Pneumococcal Vaccine Sales Forecast by Regions (2021-2025) (K Doses)
Table 67. Global Pneumococcal Vaccine Market Share Forecast by Regions (2021-2025)
Table 68. Global Pneumococcal Vaccine Sales Forecast by Type (2021-2025) (K Doses)
Table 69. Global Pneumococcal Vaccine Market Share Forecast by Type (2021-2025)
Table 70. Global Pneumococcal Vaccine Sales Forecast by Application (2021-2025)
Table 71. Global Pneumococcal Vaccine Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Pneumococcal Vaccine Picture
Figure 2. Global Sales Market Share of Pneumococcal Vaccine by Type in 2019
Figure 3. PPSV 23 Picture
Figure 4. PCV 7/13 Picture
Figure 5. PCV 10 Picture
Figure 6. Pneumococcal Vaccine Sales Market Share by Application in 2018
Figure 7. Child Picture
Figure 8. Adult Picture
Figure 9. Global Pneumococcal Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Pneumococcal Vaccine Sales Market Share by Manufacturer in 2019
Figure 30. Global Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Pneumococcal Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Pneumococcal Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 35. Global Pneumococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Pneumococcal Vaccine Revenue Market Share by Regions (2015-2020)
Figure 37. Global Pneumococcal Vaccine Revenue Market Share by Regions in 2018
Figure 38. North America Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Europe Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
Figure 41. South America Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
Figure 43. North America Pneumococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Pneumococcal Vaccine Sales Market Share by Countries (2015-2020)
Figure 45. North America Pneumococcal Vaccine Sales Market Share by Countries in 2018
Figure 46. North America Pneumococcal Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Pneumococcal Vaccine Revenue Market Share by Countries in 2018
Figure 48. United States Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 49. Canada Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 50. Mexico Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 51. Europe Pneumococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Pneumococcal Vaccine Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Pneumococcal Vaccine Revenue Market Share by Countries in 2019
Figure 54. Germany Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 55. UK Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 56. France Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 57. Russia Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 58. Italy Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 59. Asia-Pacific Pneumococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Pneumococcal Vaccine Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Pneumococcal Vaccine Revenue Market Share by Regions 2019
Figure 62. China Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 63. Japan Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 64. Korea Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 65. India Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 66. Southeast Asia Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 67. South America Pneumococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Pneumococcal Vaccine Sales Market Share by Countries in 2019
Figure 69. South America Pneumococcal Vaccine Revenue Market Share by Countries in 2019
Figure 70. Brazil Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 71. Argentina Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 72. Middle East and Africa Pneumococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Pneumococcal Vaccine Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 77. Egypt Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 78. Turkey Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 79. South Africa Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 80. Global Pneumococcal Vaccine Sales and Growth Rate (2021-2025) (K Doses)
Figure 81. Global Pneumococcal Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Pneumococcal Vaccine Market Forecast (2021-2025) (K Doses)
Figure 83. Europe Sales Pneumococcal Vaccine Market Forecast (2021-2025) (K Doses)
Figure 84. Asia-Pacific Sales Pneumococcal Vaccine Market Forecast (2021-2025) (K Doses)
Figure 85. South America Sales Pneumococcal Vaccine Market Forecast (2021-2025) (K Doses)
Figure 86. Middle East & Africa Sales Pneumococcal Vaccine Market Forecast (2021-2025) (K Doses)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
Table 1. Global Pneumococcal Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pneumococcal Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pneumococcal Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Pneumococcal Vaccine Major Business
Table 9. Pfizer Pneumococcal Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. Pfizer SWOT Analysis
Table 11. Pfizer Pneumococcal Vaccine Product and Services
Table 12. Pfizer Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Sanofipasteur Basic Information, Manufacturing Base and Competitors
Table 14. Sanofipasteur Pneumococcal Vaccine Major Business
Table 15. Sanofipasteur Pneumococcal Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. Sanofipasteur SWOT Analysis
Table 17. Sanofipasteur Pneumococcal Vaccine Product and Services
Table 18. Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. GSK Basic Information, Manufacturing Base and Competitors
Table 20. GSK Pneumococcal Vaccine Major Business
Table 21. GSK Pneumococcal Vaccine Total Revenue (USD Million) (2017-2018)
Table 22. GSK SWOT Analysis
Table 23. GSK Pneumococcal Vaccine Product and Services
Table 24. GSK Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. MSD Basic Information, Manufacturing Base and Competitors
Table 26. MSD Pneumococcal Vaccine Major Business
Table 27. MSD Pneumococcal Vaccine Total Revenue (USD Million) (2017-2018)
Table 28. MSD SWOT Analysis
Table 29. MSD Pneumococcal Vaccine Product and Services
Table 30. MSD Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. CDIBP Basic Information, Manufacturing Base and Competitors
Table 32. CDIBP Pneumococcal Vaccine Major Business
Table 33. CDIBP Pneumococcal Vaccine Total Revenue (USD Million) (2017-2018)
Table 34. CDIBP SWOT Analysis
Table 35. CDIBP Pneumococcal Vaccine Product and Services
Table 36. CDIBP Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Pneumococcal Vaccine Sales by Manufacturer (2018-2019) (K Doses)
Table 38. Global Pneumococcal Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Pneumococcal Vaccine Sales by Regions (2015-2020) (K Doses)
Table 40. Global Pneumococcal Vaccine Sales Market Share by Regions (2015-2020)
Table 41. Global Pneumococcal Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Pneumococcal Vaccine Sales by Countries (2015-2020) (K Doses)
Table 43. North America Pneumococcal Vaccine Sales Market Share by Countries (2015-2020)
Table 44. North America Pneumococcal Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Pneumococcal Vaccine Revenue Market Share by Countries (2015-2020)
Table 46. Europe Pneumococcal Vaccine Sales by Countries (2015-2020) (K Doses)
Table 47. Europe Pneumococcal Vaccine Sales Market Share by Countries (2015-2020)
Table 48. Europe Pneumococcal Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Pneumococcal Vaccine Sales by Regions (2015-2020) (K Doses)
Table 50. Asia-Pacific Pneumococcal Vaccine Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Pneumococcal Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Pneumococcal Vaccine Sales by Countries (2015-2020) (K Doses)
Table 53. South America Pneumococcal Vaccine Sales Market Share by Countries (2015-2020)
Table 54. South America Pneumococcal Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Pneumococcal Vaccine Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Pneumococcal Vaccine Sales by Countries (2015-2020) (K Doses)
Table 57. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Pneumococcal Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Pneumococcal Vaccine Revenue Market Share by Countries (2015-2020)
Table 60. Global Pneumococcal Vaccine Sales by Type (2015-2020) (K Doses)
Table 61. Global Pneumococcal Vaccine Sales Share by Type (2015-2020)
Table 62. Global Pneumococcal Vaccine Revenue by Type (2015-2020) (USD Million)
Table 63. Global Pneumococcal Vaccine Revenue Share by Type (2015-2020)
Table 64. Global Pneumococcal Vaccine Sales by Application (2015-2020) (K Doses)
Table 65. Global Pneumococcal Vaccine Sales Share by Application (2015-2020)
Table 66. Global Pneumococcal Vaccine Sales Forecast by Regions (2021-2025) (K Doses)
Table 67. Global Pneumococcal Vaccine Market Share Forecast by Regions (2021-2025)
Table 68. Global Pneumococcal Vaccine Sales Forecast by Type (2021-2025) (K Doses)
Table 69. Global Pneumococcal Vaccine Market Share Forecast by Type (2021-2025)
Table 70. Global Pneumococcal Vaccine Sales Forecast by Application (2021-2025)
Table 71. Global Pneumococcal Vaccine Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Pneumococcal Vaccine Picture
Figure 2. Global Sales Market Share of Pneumococcal Vaccine by Type in 2019
Figure 3. PPSV 23 Picture
Figure 4. PCV 7/13 Picture
Figure 5. PCV 10 Picture
Figure 6. Pneumococcal Vaccine Sales Market Share by Application in 2018
Figure 7. Child Picture
Figure 8. Adult Picture
Figure 9. Global Pneumococcal Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Pneumococcal Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Pneumococcal Vaccine Sales Market Share by Manufacturer in 2019
Figure 30. Global Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Pneumococcal Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Pneumococcal Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 35. Global Pneumococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Pneumococcal Vaccine Revenue Market Share by Regions (2015-2020)
Figure 37. Global Pneumococcal Vaccine Revenue Market Share by Regions in 2018
Figure 38. North America Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Europe Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
Figure 41. South America Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Pneumococcal Vaccine Sales and Growth Rate (2015-2020)
Figure 43. North America Pneumococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Pneumococcal Vaccine Sales Market Share by Countries (2015-2020)
Figure 45. North America Pneumococcal Vaccine Sales Market Share by Countries in 2018
Figure 46. North America Pneumococcal Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Pneumococcal Vaccine Revenue Market Share by Countries in 2018
Figure 48. United States Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 49. Canada Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 50. Mexico Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 51. Europe Pneumococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Pneumococcal Vaccine Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Pneumococcal Vaccine Revenue Market Share by Countries in 2019
Figure 54. Germany Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 55. UK Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 56. France Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 57. Russia Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 58. Italy Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 59. Asia-Pacific Pneumococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Pneumococcal Vaccine Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Pneumococcal Vaccine Revenue Market Share by Regions 2019
Figure 62. China Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 63. Japan Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 64. Korea Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 65. India Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 66. Southeast Asia Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 67. South America Pneumococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Pneumococcal Vaccine Sales Market Share by Countries in 2019
Figure 69. South America Pneumococcal Vaccine Revenue Market Share by Countries in 2019
Figure 70. Brazil Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 71. Argentina Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 72. Middle East and Africa Pneumococcal Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Pneumococcal Vaccine Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 77. Egypt Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 78. Turkey Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 79. South Africa Pneumococcal Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 80. Global Pneumococcal Vaccine Sales and Growth Rate (2021-2025) (K Doses)
Figure 81. Global Pneumococcal Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Pneumococcal Vaccine Market Forecast (2021-2025) (K Doses)
Figure 83. Europe Sales Pneumococcal Vaccine Market Forecast (2021-2025) (K Doses)
Figure 84. Asia-Pacific Sales Pneumococcal Vaccine Market Forecast (2021-2025) (K Doses)
Figure 85. South America Sales Pneumococcal Vaccine Market Forecast (2021-2025) (K Doses)
Figure 86. Middle East & Africa Sales Pneumococcal Vaccine Market Forecast (2021-2025) (K Doses)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
